CellCarta

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°C

SBTI ID

40011645

Informations générales

Localisation

Canada

Northern America

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

18/12/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon 2035

Statut

Targets set

Classification

1.5°C

Année cible

2035

Progression vers l'objectif55%
2015 (année de référence)2035
Description complète des objectifs

Near-Term Targets: CellCarta commits to reduce absolute scope 1 and 2 GHG emissions 63.0% by 2035 from a 2024 base year. CellCarta also commits to reduce absolute scope 3 GHG emissions from fuel- and energy-related activities 37.5% within the same timeframe. CellCarta further commits that 81.14% of its suppliers by emissions covering purchased goods and services, capital goods and upstream transportation and distribution, will have science-based targets by 2030.

Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Source : Science Based Targets initiative | Données publiques